Alkaline Water 10-Q/A 31 Mar 15 2014 Q1 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	Feb. 04, 2015
Document and Entity Information:
Entity Registrant Name	PureSafe Water Systems, Inc.
Entity Trading Symbol	PURE
Document Type	10-Q
Document Period End Date	31-Mar-14
Amendment Flag	FALSE
Entity Central Index Key	764839
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		1,743,981,286
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets
Cash	$12	$2,199
Inventories	141,636	141,636
Prepaid expenses and other current assets	2,657	35,437
Total Current Assets	144,305	179,272
Property and equipment, net of accumulated depreciation of $179,290 and $179,290, respectively	0	0
Patents and trademarks, net of accumulated amortization of $49,445 and $47,919, respectively	57,896	59,422
Other assets	29,250	33,500
Total Assets	231,451	272,194
Current Liabilities:
Accounts payable and accrued expenses	1,061,156	1,209,319
Accrued compensation	1,331,132	1,267,382
Accrued consulting and director fees	144,000	144,000
Notes payable to officer and director (including accrued interest of $207,104 and $193,703, respectively)	840,855	827,254
Convertible promissory note (including accrued interest of $203,871 and $154,528 and net of debt discount of $197,860and $210,781, respectively)	1,371,102	1,238,838
Promissory notes payable (including accrued interest of $247,469 and $240,807 respectively)	689,814	593,153
Fair value of detachable warrants and conversion option	518,800	299,000
Accrued dividends payable	190,328	190,328
Common stock to be issued	38,423	38,423
Total Current Liabilities	6,185,610	5,807,697
Total Liabilities	6,185,610	5,807,697
Commitments and Contingencies
Stockholders' Deficiency:
Preferred stock par value $0.001 par value; 10,000,000 shares authorized; 184,144 and 184,144 shares issued and outstanding (liquidation preference $3,052,525 and $3,025,450, as of March 31, 2014 and December 31, 2013, respectively)	184	184
Common stock par value $0.001: 2,000,000,000 shares authorized; 979,018,260 shares issued and 979,018,260 shares outstanding at March 31, 2014; 934,171,800 shares issued and 934,167,400 shares outstanding at December 31, 2013	979,017	934,171
Additional paid in capital	41,850,978	41,804,413
Treasury stock, at cost, 4,400 shares of common stock	-5,768	-5,768
Accumulated deficit	-48,778,570	-48,268,503
Total Stockholders' Deficiency	-5,954,159	-5,535,503
Total Liabilities and Stockholders' Deficiency	$231,451	$272,194

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets Parentheticals (USD $)	Mar. 31, 2014	Dec. 31, 2013
Parentheticals
Property and equipment, accumulated depreciation	$179,290	$179,290
Patents and trademarks accumulated amortization	49,445	47,919
Interest on note payable to officer and directors	207,104	193,703
Accrued interest on convertible promissory note	203,871	154,528
Convertible promissory note debt discount	197,860	210,781
Promissory notes payable, accrued interest	247,469	240,807
Preferred Stock, par value	$0.00	$0.00
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued	184,144	184,144
Preferred Stock, shares outstanding	184,144	184,144
Preferred Stock, liquidation preferencee	$3,052,525	$3,025,450
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	2,000,000,000	2,000,000,000
Common Stock, shares issued	979,018,260	934,171,800
Common Stock, shares outstanding	979,018,260	934,167,400
Treasury Stock, shares	4,400	4,400

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues:
Sales	$0	$0
Cost of Sales	0	0
Gross Profit (Loss)	0	0
Compensation and related benefits, including stock-based compensation of $0 and $394,100 for the three months ended March 31, 2014 and 2013, respectively	96,849	599,572
Insurance and medical benefits	34,382	12,544
Research and development	0	10,452
Professional, legal and consulting fees, including stock-based compensation of $0 and $177,000 for the three months ended March 31, 2014 and 2013, respectively	28,388	205,266
Marketing	0	25,000
Occupancy	15,855	57,936
Other administrative and general	19,028	46,957
Total operating expenses	194,502	957,727
Loss from operations	-194,502	-957,727
Interest income	0	4,988
Other income	0	23,538
Interest expense, including interest to related parties of $13,401 and $17,773 for the three months ended March 31, 2014and 2013, respectively	-207,765	-135,372
Change in fair value of derivative liabilities	-107,800	-326,200
Total Other Income (Expense)	-315,565	-433,046
Net Loss	-510,067	-1,390,773
Dividend on preferred stock	-27,075	-27,075
Net Loss Attributable to Common Stockholders	($537,142)	($1,417,848)
Net Loss Attributable to Common Stockholders Per Share basic and diluted	$0	$0
Weighted average number of shares outstanding	1,084,720,281	735,787,619

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Operations Parentheticals (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Statements of Operations Parentheticals
Compensation and related benefits, including stock-based compensation	$0	$394,100
Professional, legal and consulting fees, including stock-based compensation	0	177,000
Interest expense, interest to related parties	$13,401	$17,773

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Stockholders' Deficit (USD $)	Preferred Stock Shares	Preferred Stock Amount	Common Stock Shares	Common Stock Amount	Additional Paid-in Capital	Treasury Stock at Cost	Accumulated deficit	Total Stockholder's Deficiency
		USD ($)		USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Balance at Dec. 31, 2013	184,144	184	934,171,800	934,171	41,804,413	-5,768	-48,268,503	-5,535,503
Common stock issued for cashless warrant exercise		0	526,315	526	-526	0	0	0
Common stock issued for settlement of convertible debt		0	31,054,520	31,055	0	0	0	31,055
Common stock issued for penalty shares		0	13,265,625	13,265	34,491	0	0	47,756
Reclassification of derivative liability		$0		$0	$12,600	$0	$0	$12,600
Net loss		$0		$0	$0	$0	($510,067)	($510,067)
Balance at Mar. 31, 2014	184,144	184	979,018,260	979,017	41,850,978	-5,768	-48,778,570	-5,954,159

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash Flows From Operating Activities:
Net Loss	($510,067)	($1,390,773)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	0	6,808
Amortization of patents and trademarks	1,526	1,526
Interest expense - amortization of deferred financing	4,250	2,164
Interest expense - penalty interest	0	10,199
Professional fees - note conversions	375	0
Stock based compensation	0	571,100
Interest receivable	0	-4,988
Accretion of debt discount	87,920	49,763
Interest expense - derivative liabilities	49,600	0
Change in fair value of warrants and embedded conversion option	107,800	326,200
Changes in assets and liabilities:
Prepaid expenses and other current assets	32,780	-29,226
Inventories	0	138,398
Customer deposits	0	-149,588
Accounts payable, accrued expenses, accrued interest, accrued dividends, accrued compensation, accrued consulting and director fees, and other current liabilities	133,429	88,536
Net Cash Used in Operating Activities	-92,387	-379,881
Cash Flows From Investing Activities:
Patent costs	0	-7,458
Net Cash Used in Investing Activities	0	-7,458
Cash Flows From Financing Activities:
Cash proceeds from sale of common stock	0	395,000
Proceeds from convertible promissory notes	0	25,000
Repayment of convertible notes payable	0	-60,961
Cash proceeds from promissory notes, officers and directors	6,500	16,177
Repayment of officers and directors loans	-6,300	-22,125
Cash proceeds from notes payable	92,500	0
Repayment of notes payable	-2,500	0
Net Cash Provided by Financing Activities	90,200	353,091
Net decrease in cash	-2,187	-34,248
Cash at beginning of period	2,199	63,571
Cash at end of the period	12	29,323
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	20	11,537
Non-Cash Investing and Financing Activities:
Common stock issued for the settlement of liabilities	47,756	95,147
Common stock issued in connection with debt conversion	0	112,397
Common stock issued for settlement of convertible debt	30,680	0
Reclassification of derivative liabilities to equity	12,600	0
Reclassification of equity instrument to derivative liabilities	0	-112,500
Conversion of accrued liabilities to convertible notes	100,000	0
Debt discount recorded on convertible debt and warrants accounted for as derivative liabilities	$75,000	$13,600

DESCRIPTION_OF_BUSINESS

DESCRIPTION OF BUSINESS	3 Months Ended
	Mar. 31, 2014
DESCRIPTION OF BUSINESS
DESCRIPTION OF BUSINESS	NOTE 1: DESCRIPTION OF BUSINESS
	PureSafe Water Systems, Inc. (the "Company") is a Delaware corporation engaged in the design, development, manufacturing and sales of the PureSafe ™ First Response Water System (the “FRWS” ), both within and outside of the United States. The Company's corporate headquarters are located in Plainview, New York.

BASIS_OF_PRESENTATION_AND_ACCO

BASIS OF PRESENTATION AND ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2014
BASIS OF PRESENTATION AND ACCOUNTING POLICIES
BASIS OF PRESENTATION AND ACCOUNTING POLICIES	NOTE 2: BASIS OF PRESENTATION AND ACCOUNTING POLICIES.
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, these interim financial statements do not include all of the information and footnotes required for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included.
	The operating results for the three month period ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. These financial statements should be read in conjunction with the financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities and Exchange Commission on October 23, 2014.
	Principles of Consolidation
	The Company applies the guidance of Topic 810 “Consolidation” of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity. Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent company; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee. Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent’s power to control exists.
	The Company's consolidated subsidiaries and/or entities are as follows:
	Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation (date of acquisition, if applicable)	Attributable interest
	PureSafe Manufacturing and Research Corporation	Delaware	29-Sep-09	100%
	The condensed consolidated financial statements include all accounts of the Company and consolidated subsidiaries and/or entities as of March 31, 2014 and December 31, 2013 and for the three months ended March 31, 2014 and 2013.
	All significant inter-company balances and transactions have been eliminated.
	Use of Estimates
	The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The most significant estimates, among other things, are used in accounting for allowances for deferred income taxes, expected realizable values for long-lived assets (primarily intangible assets and property and equipment), contingencies, as well as the recording and presentation of its common stock and other securities. Estimates and assumptions are periodically reviewed and the effects of any material revisions are reflected in the consolidated financial statements in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.
	Inventories
	Inventory consisting primarily of finished goods and raw materials is stated at the lower of cost or market utilizing the first-in, first-out method. The Company continually analyzes its slow-moving, excess and obsolete inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves. If the Company does not meet its sales expectations, these reserves are increased. Products that are determined to be obsolete are written down to net realizable value. As of March 31, 2014, the inventory has been written down to its net realizable value.
	Deferred Financing Costs
	Cost incurred in conjunction with the debt financing has been capitalized and will be amortized to interest expense using the straight line method, which approximates the interest rate method over the term of the debt and is included as a component of other assets. Amortization of deferred financing cost was approximately $4,250 and $2,164 for the three months ended March 31, 2014 and 2013, respectively.
	Derivative Liabilities
	In connection with the issuance of certain convertible promissory notes, the terms of the convertible notes included an embedded conversion feature; which provided for the settlement of certain convertible promissory notes into shares of common stock at a rate which was determined to be variable. The Company determined that the conversion feature was an embedded derivative instrument pursuant to ASC 815 “Derivatives and Hedging”
	The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible promissory notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.
	The fair value of conversion options that are convertible at a fixed number of shares or at a fixed conversion price are recorded using the intrinsic value method and conversion options at variable rates are valued using a Black-Scholes Valuation Model. Variable conversion options are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Black-Scholes Valuation Model to be materially the same. Warrants that have been reclassified to derivative liability that did not contain “down-round protection” were valued using the black-scholes model. The Company’s outstanding warrants did not contain any down round protection.
	The Black-Scholes Valuation Model is used to estimate the fair value of the warrants and conversion option. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the instrument granted.
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Three Months Ended
		March 31,
		2014	2013
	Assumptions:
	Risk-free interest rate	0.03-1.73%	0.36-1.24%
	Expected life	.08 - 4.5 years	3- 7 years
	Expected volatility	165%-167%	168%
	Dividends	0.00%	0.00%
	Stock-Based Compensation
	The Company reports stock-based compensation under Accounting Standard Codification (“ASC”) 718 “Compensation – Stock Compensation”. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values.
	The Company accounts for equity instruments issued to non-employees as compensation in accordance with the provisions of ASC 718, which require that each such equity instrument is recorded at its fair value on the measurement date, which is typically the date the services are performed.
	For the three months ended March 31, 2014 and 2013 the Company recorded stock based compensation of $0 and $571,100, respectively.
	The Black-Scholes option valuation model is used to estimate the fair values of options. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the subject options or warrants. During the three months ended March 31, 2014 the Company has not granted any options or warrants.
	Impairment of Long-Lived Assets
	The Company assesses the recoverability of its long lived assets, including property and equipment when there are indications that the assets might be impaired. When evaluating assets for potential impairment, the Company first compares the carrying amount of the asset to the asset’s estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the asset’s estimated future cash flows (discounted and with interest charges). If the carrying amount exceeds the asset’s estimated futures cash flows (discounted and with interest charges), the loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets. Based on its assessments, the Company did not incur any impairment charges for the three months ended March 31, 2014 and 2013.
	Research and Development
	Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge, which will be useful in developing new products or processes. The Company expenses all research and development costs as incurred. The Company incurred a charge of approximately $0 and $10,452 for the three months ended March 31, 2014 and 2013, respectively.
	Subsequent Events
	The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would require adjustment or disclosure in the consolidated financial statements.

GOING_CONCERN

GOING CONCERN	3 Months Ended
	Mar. 31, 2014
GOING CONCERN
GOING CONCERN	NOTE 3: GOING CONCERN
	The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred a net loss of approximately $510,000 for the three months ended March 31, 2014. The Company has a working capital deficit of approximately $6.0 million as of March 31, 2014. The Company continues to incur recurring losses from operations and has an accumulated deficit since inception of approximately $48.8 million. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
	The Company’s continuation as a going concern is dependent upon its ability to bring the Company’s products to market and generate revenues, control costs, and obtain additional financing, as required and on reasonable terms. The Company’s plans with respect to these matters include restructuring its existing debt and raising additional financing through issuance of preferred stock, common stock and/or debt. On April 2, 2014, The Company announced that Stephen Hicks and Gilbert Steedley were appointed to the Board of Directors and that Stephen Hicks was appointed President of the Company. Henry Sargent was appointed Vice President and Secretary.
	The Company’s goal is to generate the sales of the Company's flagship mobile water purification product and to ultimately diversify its product line through ingenuity and/or acquisition. In order to accomplish these goals we are redirecting the sales effort so that the Company will no longer predominantly focus on the government sector, a target with historically long lead times. In addition the Company is reviewing the entire approach to the product with an aim to 1) deepen and diversify our distribution channels, 2) lower our cost of production, 3) improve the Company's profit margin on and 4) maintain an inventory of units for immediate sale.
	The Company requires immediate capital to remain viable. The Company can give no assurance that such financing will be available on terms advantageous to the Company, or at all. Should the Company not be successful in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all of its operational activities. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
	Subsequent to March 31, 2014, the Company has issued approximately $100,000 of notes payable and approximately $392,000 of convertible notes payable. From April 1, 2014 until December 3, 2014, the Company issued 803,214,844 shares of common stock for the settlement of $218,920 loan principal plus $46,689 accrued interest, penalties and fees. Currently the Company has cash of approximately $1,000 available for use.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2014
RECENT ACCOUNTING PRONOUNCEMENTS
RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 4: RECENT ACCOUNTING PRONOUNCEMENTS.
	The FASB and the SEC have issued certain accounting standards updates and regulations that will become effective in subsequent periods; however, management of the Company does not believe that any of those updates would have significantly affected the Company’s financial accounting measures or disclosures had they been in effect during 2014 or 2013, and does not believe that any of those pronouncements will have a significant impact on the Company’s consolidated financial statements at the time they become effective.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2014
INVENTORIES
INVENTORIES	NOTE 5: INVENTORIES
	Inventories consist of the following at March 31, 2014 and December 31, 2013:
		March 31,		31-Dec-13
		2014
	Finished Goods	$	141,636	$	141,636
	Total	$	141,636	$	141,636

NET_LOSS_PER_SHARE_OF_COMMON_S

NET LOSS PER SHARE OF COMMON STOCK	3 Months Ended
	Mar. 31, 2014
NET LOSS PER SHARE OF COMMON STOCK
NET LOSS PER SHARE OF COMMON STOCK	NOTE 6: NET LOSS PER SHARE OF COMMON STOCK.
	Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants, convertible preferred stock and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.
	Total shares issuable upon the exercise of warrants and conversion of preferred stock and convertible promissory notes for the three months ended March 31, 2014 and 2013 were as follows:
		March 31,
		2014		2013
	Warrants	175,999,286		148,166,128
	Convertible promissory notes	502,849,869		58,547,970
	Convertible preferred stock	1,545,760		1,545,760
	Total	680,394,915		208,259,858
	For the three months ended March 31, 2014 and 2013, 130,172,245 and 81,456,675 warrants were included in loss per share as their exercise price was determined to be nominal.
	Fair Value
	ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.
	ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:
	·
	Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
	·
	Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.
	·
	Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.
	In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair measurements requires judgment and considers factors specific to each asset or liability.
	Liabilities measured at fair value on a recurring basis at March 31, 2014 are as follows:
		Quoted Prices in Active Markets for Identical Liabilities			Significant Other Observable Inputs		Significant Unobservable Inputs		Balance
		(Level 1)			(Level 2)		(Level 3)
	Embedded conversion feature	$	–		$	–	$	395,500	$	395,500
	Warrant liability	$	–		$	–	$	123,300	$	123,300
	Balance at March 31, 2014	$	–		$	–	$	518,800	$	518,800
	Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The Company’s Level 3 liabilities consist of derivative liabilities associated with convertible debt that contains an indeterminable conversion share price and the tainted warrants as the Company cannot determine if it will have sufficient authorized common stock to settle such arrangements.
	The following table provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets measured at fair value on a recurring basis using significant unobservable inputs during the three months ended March 31, 2014.
					Conversion
		Warrants			Feature		Total
	Balance at - December 31, 2013	$	92,500		$	206,500	$	299,000
	Included in stock based compensation		–			–		–
	Change in fair value of derivative liability		32,400			75,400		107,800
	Included in liabilities (debt discount)		–			75,000		75,000
	Included in liabilities (derivative expense)		–			49,600		49,600
	Included in stockholder's equity		-1,600			-11,000		-12,600
	Transfers in and /or out of Level 3		–			–		–
	Balance at - March 31, 2014	$	123,300		$	395,500	$	518,800

NOTES_PAYABLE

NOTES PAYABLE	3 Months Ended
	Mar. 31, 2014
NOTES PAYABLE
NOTES PAYABLE	NOTE 7: NOTES PAYABLE
	(a)
	From January 15, 2014 through February 23, 2014 the Company issued Promissory Notes in the aggregate principal amount of $90,000 to seven lenders. The Notes bear no interest and mature one year from the date of issuance. A UCC financing statement was filed on the system operating at the Landfill as security for the Notes. As of March 31, 2014 the outstanding principal balance on the notes was $90,000.

CONVERTIBLE_PROMISSORY_NOTES_P

CONVERTIBLE PROMISSORY NOTES PAYABLE	3 Months Ended
	Mar. 31, 2014
CONVERTIBLE PROMISSORY NOTES PAYABLE
CONVERTIBLE PROMISSORY NOTES PAYABLE	NOTE 8: CONVERTIBLE PROMISSORY NOTES PAYABLE
	(a)
	On May 25, 2013, in conjunction with a liabilities purchase agreement with ASC Recap, LLC (“ASC Recap”), the Company issued ASC Recap a convertible promissory note in the principal amount of $25,000. The convertible note matured November 30, 2013. The convertible promissory note shall be convertible into the common stock of the Company at any time at a conversion price equal to 50% of the low closing bid price for the twenty days prior to conversion.
	During the three months ended March 31, 2014, the note holder requested to convert total aggregated $25,000 principal plus fees of $375, into the Company’s common stock. The Company issued total aggregated 25,375,000 shares of common stock in connection with such conversion.
	(b)
	On January 31, 2014, in conjunction with a settlement agreement with Tarpon Bay Partners, LLC (“Tarpon”), the Company issued Tarpon a convertible promissory note in the principal amount of $75,000. The convertible note matures one year from the date of issuance with interest at 10% per annum. The convertible promissory note shall have no registration rights and shall be convertible into the common stock of the Company at any time at a conversion price equal to 75% of the low closing bid price for the twenty days prior to conversion.
	The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 “Derivatives and Hedging”. Accordingly, the embedded conversion option of the convertible notes are recorded as derivative liabilities at their fair market value and are marked to market through earnings at the end of each reporting period. The gross proceeds from the sale of the note are recorded net of a discount of $75,000. The debt discount relates to fair value of the conversion option. The debt discount is charged to interest expense ratably over the term of the convertible note. The fair value of the conversion option on the date of issuance in excess of the face amount of the note was recorded to interest expense on the date of issuance.
	As of March 31, 2014, the Company is reflecting liabilities of $76,229 including accrued interest of $1,229.
	(c)
	During the three months ended March 31, 2014 the Company issued a total of 31,054,520 shares of common stock upon requests from note holders to convert loans with principal plus accrued interest totaling $31,055 based on the terms set forth in the loans.

CONVERTIBLE_NOTES_AND_NOTES_PA

CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	3 Months Ended
	Mar. 31, 2014
CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR
CONVERTIBLE NOTES AND NOTES PAYABLE - OFFICERS & DIRECTOR	NOTE 9: CONVERTIBLE NOTES AND NOTES PAYABLE – OFFICERS & DIRECTOR
	(a)
	During March 2014, the Company’s Chief Executive Officer made a short term loan of $6,500 to the Company. This loan was intended to be repaid within 2 months. No documents were prepared nor interest accrued. During 2014 $6,300 was repaid. As of March 31, 2014 the Company is reflecting a liability of $200. The Company is not compliant with the repayment terms.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2014
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 10: COMMITMENTS AND CONTINGENCIES
	Operating Leases
	35 East Mall
	In June 2014 the Company entered into an operating lease for its Plainview N.Y. office facility for a period of six months starting in July 2014. The Company will pay monthly rental payments of $1,050. The lease may be renewed in six month increments, with forty-five days’ notice and is subject to a 5% increase per annum.
	Litigation
	Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.
	In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.
	If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.
	Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed. There can be no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. As of March 31, 2014, the Company has the following litigation outstanding.
	The Company is a defendant in a suit in the Supreme Court of the State of New York, County of Nassau, filed by Fairchild Warehouse Associates, LLC (“Fairchild”), as plaintiff, for recovery of past rental payments for the Company’s former office space at 25 Fairchild Avenue, Plainview, New York 11803, with money damages, as of February 2014, requested in the amount of $475,930, which have been accrued for and included in accounts payable and accrued liabilities as of March 31, 2014. An inquest began on December 10, 2014 to determine the amount of money damages due on Fairchild’s claim. Currently, the Company is waiting for a judgment.
	The Company on April 4, 2013, was served with a summons and complaint, filed with the Supreme Court of the State of New York, County of New York, Levin Consulting Group, LLC (“Levin”), as plaintiff, where the plaintiff is claiming that additional shares of the Company’s Common Stock are issuable by the Company to plaintiff in connection with the exercise by plaintiff of a common stock purchase warrant issued by the Company. The warrant was originally issued contemporaneously with the issuance of a $20,000 promissory note to Levin. In June 2014 the Company entered into a settlement and has agreed to issue a convertible promissory note in the amount of $50,000 to the plaintiff. The convertible note matures on December 31, 2015 and accrues interest at 10% per annum. The holder may convert all or any portion of the outstanding principal and accrued and unpaid interest due and payable under the note into shares of the Company’s common stock at a conversion price equal to 50% of the lowest closing bid price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to the lender not being able to beneficially own more than 9.999% of our outstanding common stock upon any conversion. If the closing bid price for the common stock on the date in which the conversion shares are deposited into the holders brokerage account and the holder may execute trades of the conversion shares (“the “Clearing Date”) then the conversion price shall be adjusted such that the discount be taken from the closing bid price on the Clearing Date. The original $20,000 note remains outstanding. As of March 31, 2014 the Company has accrued a $50,000 loss as a result of the settlement and is included in accounts payable and accrued liabilities.
	The Company is in default under a May 30, 2012, Securities Purchase Agreement entered into with TCA Global Credit Master Fund, LP (“TCA”), providing for the issuance of $275,000 principal amount of senior secured redeemable and convertible debentures due November 30, 2012. On October 4, 2013, at the request of the lender due to default, the Company converted $303,499 of convertible notes and accrued interest into a new convertible note in the amount of $531,431. The increase in principal was due to amounts charged by the lender for penalties, interest, legal and other fees. The newly issued note bears interest at rates of 18% per annum and is due on demand. The lender may convert all or any portion of the outstanding principal, accrued and unpaid interest, and any other sums due and payable under the Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest daily volume weighted average price of the Company’s common stock during the five trading days immediately prior to such applicable conversion date, in each case subject to the lender not being able to beneficially own more than 4.99% of our outstanding common stock upon any conversion. The conversion price is subject to anti-dilution protection in the event that the Company issues additional equity securities at a price less than the conversion price. On March 10, 2014, TCA accelerated the outstanding principal balance, interest, calculated at the default rate of 18%, and all sums due under the original note and any amendments. In August 2014 a default final judgment was entered against the Company concluding that TCA is entitled to damages in the amount of $610,349, to foreclose upon the security interests, and to recover attorneys’ fees and costs incurred by TCA. In addition prejudgment interest shall be assessed at a rate of 18% per annum and post judgment interest shall be assessed at a rate of 4.75% per annum. As of March 31, 2014 the Company has accrued a liability of $578,279 related to the TCA claim and is included in convertible notes payable.
	On November 27, 2013, the Company entered into a settlement agreement with Tarpon Bay Partners LLC (“Tarpon”), a related party. The manager of Tarpon is Stephen Hicks, the President of the Company. Tarpon previously purchase outstanding liabilities of the Company from TCA in the amount of $506,431 and Designs and Project Development Corporation (a former landlord) in the amount of $56,429. Per the terms of the settlement the Company was to issue Tarpon shares of common stock in one or more tranches as necessary, and subject to adjustment and ownership limitations, and a convertible promissory note in the principal amount of $75,000. The Company failed to issue shares to Tarpon and in the first quarter of 2014 TCA rescinded its liabilities purchase agreement with Tarpon. As of March 31, 2014 the Company has accrued a liability of $58,273 related to the Designs and Project Development Corporation claim and is included in notes payable and the $506,431 related to TCA has been included in convertible promissory notes.
	On January 31, 2014, in conjunction with the settlement agreement outlined above, the Company issued Tarpon a convertible promissory note in the principal amount of $75,000. The convertible note matures one year from the date of issuance with interest at 10% per annum. The convertible promissory note has no registration rights and shall be convertible into the common stock of the Company at any time at a conversion price equal to 75% of the low closing bid price for the twenty days prior to conversion.
	An eviction notice was issued on October 8 by the landlord for 160 Dupont Street, Five Towns Realty Associates, Inc (“Five Towns Realty”). There is currently an outstanding balance of $54,739 that is subject to a lawsuit and is included in accounts payable and accrued liabilities at March 31, 2014. The Company is currently in negotiations with Five Towns Realty to reach a settlement.
	An action was commenced on March 22, 2012, in the Supreme Court of the New York for the County of Nassau, by Lazar, Sanders Thaler & Associates, LLP, a dissolved accounting firm of which Terry R. Lazar, the Company’s former CFO was a member. Among the parties named as defendants were Mr. Lazar and the Company. The claim was made that the Company owned fees to the plaintiff and/or that such fees were paid to Terry Lazar who never forwarded them to the plaintiff. Mr. Lazar undertook the defense of the action on his behalf and on behalf of the Company.
	The matter proceeded to inquest and the court awarded judgment to the plaintiff against the Company in the sum of $25,000. Adding interests and costs to the awarded amount, judgment has been entered against the Company in the total sum of $36,613. An appeal has been taken from the judgment. The appeal has been perfected by the filing of the record and brief in the Supreme Court of the state of New York. As of March 31, 2014 the Company has accrued a liability of $36,613 related to the judgment and is included in accounts payable and accrued liabilities at March 31, 2014.
	On October 23, 2014, the Company received a notice, filed with the Office of the District Administrative Judge, 10th Judicial District, Nassau County, New York, of the Company’s right to arbitrate a fee dispute with Steve Legum over $12,194 of legal fees in connection with Mr. Legum’s representation of the Company in the Levin Consulting Group matter. The Company did not file the Request for Fee Arbitration within the required 30 days of receipt of the notice, thereby forfeiting its right elect to resolve the dispute by arbitration. As of March 31, 2014 the Company has accrued a liability of $6,022 related to the dispute and is included in accounts payable and accrued liabilities at March 31, 2014.

STOCKHOLDERS_DEFICIENCY

STOCKHOLDERS' DEFICIENCY	3 Months Ended
	Mar. 31, 2014
STOCKHOLDERS' DEFICIENCY
STOCKHOLDERS' DEFICIENCY	NOTE 11: STOCKHOLDERS' DEFICIENCY.
	During the three months ended March 31, 2014, the Company recorded the following transactions:
	Debt
	During the three months ended March 31, 2014, the Company issued a total of 31,054,520 shares of common stock upon the requests from note holders to convert principal plus accrued interest and fees totaling $31,055 into the Company’s common stock based on the terms set forth in the loans. The conversion rate was $0.001 per share.
	On January 8, 2014, the Company issued 13,265,625 shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $47,756 of interest expense during 2013 for such issuance.
	On March 13, 2014, a warrant holder exercised 625,000 warrants at exercise price of $0.0025. The holder elected their cash-less exercise provision. Accordingly, the Company issued 526,315 shares of common stock in connection with such exercise.

STOCK_WARRANTS

STOCK WARRANTS	3 Months Ended
	Mar. 31, 2014
STOCK WARRANTS
STOCK WARRANTS	NOTE 12: STOCK WARRANTS
	The following warrants were exercised:
	The three months ended March 31, 2014
	75,000
	The following warrants expired:
	The three months ended March 31, 2014
	500,000
	The following tables sets forth information concerning the Company's warrant issuances and warrant balances outstanding as of, and during the three months ended March 31, 2014:
		Shares Underlying Warrants	Weighted Average Exercise Price			Intrinsic Value
	Outstanding at December 31, 2013	176,574,286	$	0.02		$	-
	Granted	-		-			-
	Expired	-500,000		0.135			-
	Exercised	-75,000		0.025			-
	Outstanding at March 31, 2014	175,999,286		0.01			-
	The following is additional information with respect to the Company's warrants as of March 31, 2014:
	Number of Warrants	Range of Exercise Price	Weighted Average Remaining Contractual Life (In Years)		Average Exercise Price			Currently Exercisable
	129,078,495	$0.003-$0.0096	3.51		$	0.0051		129,078,495
	44,233,863	$0.0108-$0.0964	1.08		$	0.0362		44,233,863
	2,627,404	$0.1-$0.1884	2.91		$	0.1139		2,627,404
	59,524	$0.84	1.66		$	0.84		59,524
	175,999,286							175,999,286

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2014
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 13: SUBSEQUENT EVENTS
	On April 2, 2014, the Company Board of Directors elected Stephen M. Hicks to the Board of Directors, to fill a vacancy on the Board, and as President of the Company. Mr. Hicks is the Chief Executive Officer of Southridge LLC (“Southridge.”) Southridge and its affiliates have financed the Company in the past and continue to own debt and equity securities of the Company. New directors, who are not officers, are paid $12,500 per year in cash or stock.
	On April 2, 2014, the Company Board of Directors elected Mr. Gilbert Steedley to the Board to fill a vacancy on the Board. Mr. Steedley is currently interim Chief Executive Officer and Director of Accelpath, New York, N.Y. Compensation is as indicated above for Mr. Hicks.
	On April 2, 2014, the Company elected Henry Sargent as Vice President and Secretary of the Company. Mr. Sargent is Chief Operating Officer and General Counsel of Southridge.
	Issuance of Common Stock
	From April 1, 2014 until October 28, 2014, the Company converted a total of $189,620 loan principal plus $23,795 accrued interest and fees into 383,758,189 shares of common stock.
	On August 27, 2013 the Company received proceeds of $10,500 for the exercise of 1,093,750 warrants and as of December 31, 2013 the shares had not been issued and accordingly the Company recorded the liability for the share issuance. On August 19, 2014 the Company issued the warrant holder 9,545,455 shares which represented the fair value of $10,500 of the proceeds received.
	On July 9, 2013 the Company received proceeds of $27,923 for the exercise of 2,389,817 warrants and as of December 31, 2013 the shares had not been issued and accordingly the Company recorded the liability for the share issuance. On August 19, 2014 the Company issued the warrant holder 27,202,727 shares which represented the fair value of $27,923 of the proceeds received.
	On July 1, 2014, the Company issued 7,634,921 shares of common stock to a note lender for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $12,979 of interest expense for such issuance.
	On September 15, 2014, the Company issued 7,027,778 shares of common stock to a note lender for failing to issue shares timely upon receipt of the conversion notice from the lender. The Company recorded $4,919 of interest expense for such issuance.
	Issuance of Promissory Notes
	On April 25, 2014 the Company issued a promissory note for $ 100,000. The note matures on April 30, 2015 with the stated interest rate at 8%.
	Issuance of Convertible Promissory Notes
	On April 4, 2014 the Company issued a convertible promissory note for $ 50,000 to a related party. The note matures in one year from the issuance date with the stated interest rate at 0%. The note is convertible into the Company’s common stock at a 40% discount of the lowest closing bid price during the 30 trading days prior to conversion.
	On April 21, 2014 the Company issued a convertible promissory note to a related party for $2,500. The note matures on April 30, 2015 with the stated interest rate at 0%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 30 trading days prior to conversion.
	On June 19, 2014 the Company issued a convertible promissory note for $ 100,000. The note matures on December 31, 2014 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.0019 per share. In addition, 10,526,316 warrants were issued with an exercise price of $0.00228 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	On July 17, 2014 the Company issued a convertible promissory note for $ 23,000. The note matures on June 30, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.001 per share. In addition, 4,600,000 warrants were issued with an exercise price of $0.0012 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	On July 17, 2014 the Company issued a convertible promissory note for $ 20,000. The note matures on December 31, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 10 trading days prior to conversion.
	On August 13, 2014 the Company issued a convertible promissory note for $ 85,000. The note matures on June 30, 2015 with the stated interest rate at 8%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 20 trading days prior to conversion.
	On September 16, 2014 the Company issued a convertible promissory note for $ 23,000. The note matures on June 30, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.0005 per share. In addition, 9,200,000 warrants were issued with an exercise price of $0.0006 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	On October 21, 2014 the Company issued a convertible promissory note for $ 50,000. The note matures on May 01, 2015 with the stated interest rate at 0% and a premium to be paid on redemption of $20,000. Upon maturity, at the election of the holder, the note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 10 trading days prior to conversion.
	On October 22, 2014 the Company issued a convertible promissory note for $ 14,000. The note matures on September 30, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a conversion price of $0.0004 per share. In addition, 7,000,000 warrants were issued with an exercise price of $0.00048 per share. The warrants are fully vested and have a life of 5 years from date of issuance.
	On November 10, 2014 the Company issued a convertible promissory note for $ 20,000. The note matures on October 31, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 30 trading days prior to conversion.
	On November 17, 2014 the Company issued a convertible promissory note for $ 4,156. The note matures on October 31, 2015 with the stated interest rate at 10%. The note is convertible into the Company’s common stock at a 50% discount of the lowest closing bid price during the 30 trading days prior to conversion.
	Entry Into A Material Definitive Agreement
	On June 13, 2014, the Company entered into a consulting agreement (the “Consulting Agreement”) with Tarpon Bay Partners, LLC, a Florida limited liability company (“Tarpon”), for the period from the date of the agreement through March 31, 2015. The agreement requires Tarpon to provide general management and consulting services and advisory services to the Company, including assistance in connection with the restructuring of its outstanding debt and equity securities. The manager of Tarpon is Stephen Hicks, the President of the Company.
	Pursuant to the terms of the Consulting Agreement, Tarpon will be compensated by the issuance to it by the Company of shares of Series H Convertible Preferred Stock. Pursuant to the terms of the Consulting Agreement, Tarpon will receive Series H Preferred Stock with a stated value of $425,000 upon the execution of the Agreement, and additional Series H Preferred Stock with a stated value of $75,000 monthly, commencing July 1, 2014 and continuing through the balance of the term. Tarpon has waived the monthly issuances of Series H Preferred Stock for the months of November and December, 2014. The execution and delivery of the Consulting Agreement was approved by the directors of the Company. Mr. Hicks did not participate in the vote on this matter.
	On June 13, 2014, the Company entered into an Equity Purchase Agreement with an accredited investor. The terms of the Equity Purchase Agreement provide that the Investor agrees, subject to put notices from the Company, to purchase up to $5,000,000 in Common Stock during the 24 months following the execution of the Agreement, subject to certain conditions and limitations. For each closing, the purchase price of the Common Stock will be 90% of the average of the three lowest Closing Bid Prices during the 10 trading days following the relevant Clearing Date (as defined in the Equity Purchase Agreement). In connection therewith, the Company also entered into a Registration Rights Agreement with the investor, pursuant to which the Company is required to file a Registration Statement with the Securities and Exchange Commission for the expected number of shares to be issued under the Equity Purchase Agreement within 120 days of the date of the Registration Rights Agreement. The Investor also provided the Company with a one year loan of $100,000; the obligation to repay this loan is represented by a Promissory Note issued by the Company to the Investor.
	Series A and Series F Preferred Stock
	On June 3, 2014, the Company filed with the Secretary of State of the State of Delaware Certificates of Correction to its existing Certificates of Designations for its Series A and Series F Preferred Stock, respectively. These filings reduced the number of authorized shares of the Company’s Series A Preferred Stock from the previously reported 400,000 shares to 52,500 shares and the number of authorized shares of the Series F Preferred Stock from the previously reported 1,000,000 shares to 38,644 shares. In each case, the current number of outstanding shares (as of the date of filing of each Certificate of Correction, 2014) of the relevant Series is not more than the number of authorized shares specified in the corresponding Certificate of Correction.
	Series G Preferred Stock
	On June 13, 2014, the number, designation, rights, preferences and privileges of the Series G Preferred Stock were established by the Board. The designation, rights, preferences and privileges that the Board established for the Series G Preferred Stock are set forth in a Certificate of Designations that was filed with the Secretary of State of the State of Delaware on June 17, 2014. Among other things, the Certificate of Designation provides that each one share of Series G Preferred has voting rights equal to (x) (i) 0.019607 multiplied by the total issued and outstanding Common Stock eligible to vote at the time of the respective vote (the number determined by this clause (i), the “Numerator”), divided by (ii) 0.49, minus (y) the Numerator. These voting rights apply only to matters of Company capitalization (i.e. increase in authorized common stock, stock splits, etc.), and similar matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent.The Series G has a par value of $0.001 per share, no rights to dividends but provides for liquidation rights which entitle the holder to a pro-rata share of net assets. Each Series G share is convertible, at the option of the holder, into one share of Common Stock. The Company issued 51 shares of the Series G to the President.
	Material Modification to Rights of Security Holders
	By unanimous written consent of the Board (Mr. Hicks not participating), the Board authorized the filing of a Certificate of Designation for its Series G Convertible Preferred Stock (“Series G Preferred Stock”) and the issuance of all of the fifty-one (51) authorized shares of such Series G Preferred Stock to Stephen Hicks (the “Series G Stockholder”) for a purchase price of $1 per share. As a result of the voting rights granted to the Series G Preferred Stock in the Certificate of Designations, the Series G Stockholder holds in the aggregate approximately 51% of the total voting power of all issued and outstanding voting capital of the Company. Pursuant to the terms of the Board resolution authorizing the issuance of the Series G Preferred Stock, and authorizing the issuance of the shares to Mr. Hicks, the Company has the right to redeem said Preferred Stock of the Company upon his resignation or the termination of his services as President of the Company. The Company believes that the issuance of the Series G Preferred Stock to Mr. Hicks will facilitate the Company’s ability to manage its affairs.
	Series H Preferred Stock
	On June 13, 2014, the number, designation, rights, preferences and privileges of the Series H Preferred Stock were established by the Board. The designation, rights, preferences and privileges that the Board established for the Series H Preferred Stock are set forth in a Certificate of Designations that was filed with the Secretary of State of the State of Delaware on June 17, 2014.
	The Certificate of Designations for the Series H Preferred Stock provides for the issuance of up to 1,000 shares of Series H stock with a stated value of $25,000 per share. As long as any shares of Series H Preferred Stock remain outstanding, the Company cannot, without the consent of the holders of at least 90% of the Series H Preferred Stock, redeem, repurchase or otherwise acquire any junior securities, or pay or make any distribution upon any junior securities as defined therein.
	The Series H Preferred Stock is convertible at the option of the holder into such number of shares upon the conversion ratio equal to the aggregate stated value of the Series H Preferred Stock converted divided by the average closing bid price for the calendar month preceding the original issuance date of the shares being converted, as reported by the reporting service. The Company is required to reserve a sufficient number of shares of common stock as may be required to be issued thereunder. The conversion ratio is subject to adjustment, from time to time, for various reasons including a sale or merger by the Company.
	With respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of the outstanding shares of Series H Preferred Stock shall vote together with the holders of Common Stock without regard to class, except as to those matters on which separate class voting is required by applicable law or the Articles of Incorporation or bylaws.
	On September 30, 2014 the Company entered into an agreement in-order to satisfy an outstanding liability of the Company to our former Vice President of International Markets, Shaul Kochan, dating back to 2009. Per the terms of the agreement the Company shall issue 110 shares of preferred stock with a stated value equal to $110,000. The Company has agreed to redeem the preferred stock in 14 separate tranches at the beginning of each calendar month beginning October 1, 2014, pursuant to the following schedule: $5,000 in stated value worth of shares each month for the first 4 months; $7,500 in stated value worth of shares each month for the subsequent 6 tranches; $10,000 in stated value worth of shares each month for the subsequent 3 tranches; and $15,000 in stated value worth of shares in the final month.
	If the Company misses payment of any tranche it will have 30 calendar days in which to cure such payment, after which time the Company agrees to issue additional shares of preferred stock representing 1% of the aggregate stated value of the then outstanding preferred stock held by Mr. Kochan, redeemable under similar terms.
	In addition, the Company agrees to extend the maturity date of the outstanding warrant held by Mr. Kochan from its current expiration date of March 7, 2015 to March 7, 2017. The Company further agrees to issue an additional warrant to Mr. Kochan for right to exercise and purchase 2,000,000 shares of the Company’s common stock at an exercise price of $0.052 and maturity date of March 7, 2017.
	Entry Into A Material Definitive Agreement
	On October 24, 2014, the Company entered into an agreement in-order to satisfy outstanding liabilities of the Company due to our former Chief Financial Officer (“CFO”) and Former Director, Terry R. Lazar (“Lazar”), dating back to 2009. Mr. Lazar acted as CFO for the Company until February 15, 2014, and the Company has accrued approximately $485,000 in deferred compensation on behalf of Lazar, including accrued warrants for his services on the Company’s Board (“Deferred Comp”). In addition, Lazar has loaned approximately $225,000 to the Company in the form of loans(s) (“Loan”). Mr. Lazar and the Company have agreed to satisfy and terminate all Deferred Comp and Loan obligations of the Company due to Lazar by having the Company issue to Lazar a new series of preferred stock.
	Per the terms of the agreement the Company shall issue 200 shares of preferred stock with a stated value equal to $200,000. The preferred stock shall carry an annual dividend yield of 5%, and shall be convertible into 100,000,000 shares of common stock at the option of Lazar. The Company has the option to redeem the preferred stock at any time for an amount equal to its stated value plus any accrued dividend by paying cash to Lazar subject to a conversion notice tendered by the holder within five days from receipt of a redemption notice.
	Definitive Information Statement filed with SEC for Capital Increase and Reverse Stock Split
	A Preliminary Information Statement was filed with the SEC on October 24, 2014, and the Definitive Information Statement on December 11, 2014, to notify the Company’s stockholders that on October 24, 2014, our stockholders approved the following amendments (the “Amendments”) to our Certificate of Incorporation: (1) a Reverse Stock Split of the Company’s common stock at a ratio of not less than one-for-one hundred and not more than one-for-five hundred as determined by our Board of Directors (the “Reverse Stock Split”), subject to the Board’s discretion to determine, without any further action by stockholders, not to proceed with a reverse stock split if it determines that a reverse stock split is no longer in the best interest of the Company and its stockholders, and (2) the authorization of an increase in the number of authorized shares of common stock from two billion (2,000,000,000) shares of common stock, par value $.001 per share, to ten billion (10,000,000,000) shares of common stock, par value $.00001 per share (the “Authorized Share Increase”). The Company currently has no commitments for the issuance of any shares of common stock or preferred stock, other than as provided for in existing agreements and instruments to which it is a party. The Company received stockholder approval for the Amendments pursuant to a written consent from the holder of all of the outstanding shares of the Company’s Series G Preferred Stock, a super voting preferred stock. The majority holder approved the Amendments by written consent in lieu of a meeting on October 24, 2014. The Amendments (which includes the Authorized Share Increase and Reverse Stock Split) will become effective when we file the Certificate of Amendment with the Secretary of State of the State of Delaware, subject to, following Board determination of the Reverse Stock Split ratio, our filing for approval of and an effective date for the Reverse Stock Split with the Financial Industry Regulatory Authority (FINRA). The Amendments will not be filed, and will not become effective, until the date that is at least 20 days after December 15, 2014, the date on which the Definitive Information Statement was first mailed or otherwise delivered to our stockholders.

ACCOUNTING_POLICIES_POLICIES

ACCOUNTING POLICIES (POLICIES)	3 Months Ended
	Mar. 31, 2014
ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, these interim financial statements do not include all of the information and footnotes required for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included.
	The operating results for the three month period ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. These financial statements should be read in conjunction with the financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities and Exchange Commission on October 23, 2014.
Principles of Consolidation	Principles of Consolidation
	The Company applies the guidance of Topic 810 “Consolidation” of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity. Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent company; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee. Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent’s power to control exists.
	The Company's consolidated subsidiaries and/or entities are as follows:
	Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation (date of acquisition, if applicable)	Attributable interest
	PureSafe Manufacturing and Research Corporation	Delaware	29-Sep-09	100%
	The condensed consolidated financial statements include all accounts of the Company and consolidated subsidiaries and/or entities as of March 31, 2014 and December 31, 2013 and for the three months ended March 31, 2014 and 2013.
	All significant inter-company balances and transactions have been eliminated.
Use of Estimates	Use of Estimates
	The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The most significant estimates, among other things, are used in accounting for allowances for deferred income taxes, expected realizable values for long-lived assets (primarily intangible assets and property and equipment), contingencies, as well as the recording and presentation of its common stock and other securities. Estimates and assumptions are periodically reviewed and the effects of any material revisions are reflected in the consolidated financial statements in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.
Inventories	Inventories
	Inventory consisting primarily of finished goods and raw materials is stated at the lower of cost or market utilizing the first-in, first-out method. The Company continually analyzes its slow-moving, excess and obsolete inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves. If the Company does not meet its sales expectations, these reserves are increased. Products that are determined to be obsolete are written down to net realizable value. As of March 31, 2014, the inventory has been written down to its net realizable value.
Deferred Financing Costs	Deferred Financing Costs
	Cost incurred in conjunction with the debt financing has been capitalized and will be amortized to interest expense using the straight line method, which approximates the interest rate method over the term of the debt and is included as a component of other assets. Amortization of deferred financing cost was approximately $4,250 and $2,164 for the three months ended March 31, 2014 and 2013, respectively.
Derivative Liabilities	Derivative Liabilities
	In connection with the issuance of certain convertible promissory notes, the terms of the convertible notes included an embedded conversion feature; which provided for the settlement of certain convertible promissory notes into shares of common stock at a rate which was determined to be variable. The Company determined that the conversion feature was an embedded derivative instrument pursuant to ASC 815 “Derivatives and Hedging”
	The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date. As a result of entering into the convertible promissory notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassesses the classification at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.
	The fair value of conversion options that are convertible at a fixed number of shares or at a fixed conversion price are recorded using the intrinsic value method and conversion options at variable rates are valued using a Black-Scholes Valuation Model. Variable conversion options are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Black-Scholes Valuation Model to be materially the same. Warrants that have been reclassified to derivative liability that did not contain “down-round protection” were valued using the black-scholes model. The Company’s outstanding warrants did not contain any down round protection.
	The Black-Scholes Valuation Model is used to estimate the fair value of the warrants and conversion option. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the instrument granted.
	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Three Months Ended
		March 31,
		2014	2013
	Assumptions:
	Risk-free interest rate	0.03-1.73%	0.36-1.24%
	Expected life	.08 - 4.5 years	3- 7 years
	Expected volatility	165%-167%	168%
	Dividends	0.00%	0.00%
Stock-Based Compensation	Stock-Based Compensation
	The Company reports stock-based compensation under Accounting Standard Codification (“ASC”) 718 “Compensation – Stock Compensation”. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values.
	The Company accounts for equity instruments issued to non-employees as compensation in accordance with the provisions of ASC 718, which require that each such equity instrument is recorded at its fair value on the measurement date, which is typically the date the services are performed.
	For the three months ended March 31, 2014 and 2013 the Company recorded stock based compensation of $0 and $571,100, respectively.
	The Black-Scholes option valuation model is used to estimate the fair values of options. The model includes subjective input assumptions that can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the subject options or warrants. During the three months ended March 31, 2014 the Company has not granted any options or warrants.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
	The Company assesses the recoverability of its long lived assets, including property and equipment when there are indications that the assets might be impaired. When evaluating assets for potential impairment, the Company first compares the carrying amount of the asset to the asset’s estimated future cash flows (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset to the asset’s estimated future cash flows (discounted and with interest charges). If the carrying amount exceeds the asset’s estimated futures cash flows (discounted and with interest charges), the loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets. Based on its assessments, the Company did not incur any impairment charges for the three months ended March 31, 2014 and 2013.
Research and Development	Research and Development
	Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge, which will be useful in developing new products or processes. The Company expenses all research and development costs as incurred. The Company incurred a charge of approximately $0 and $10,452 for the three months ended March 31, 2014 and 2013, respectively.
Subsequent Events	Subsequent Events
	The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would require adjustment or disclosure in the consolidated financial statements.

Principal_assumptions_used_in_

Principal assumptions used in applying the Black-Scholes model (Tables)	3 Months Ended
	Mar. 31, 2014
Principal assumptions used in applying the Black-Scholes model
Schedule of Assumptions Used applying the Black-Scholes model were as follows	The principal assumptions used in applying the Black-Scholes model were as follows:
		For the Three Months Ended
		March 31,
		2014	2013
	Assumptions:
	Risk-free interest rate	0.03-1.73%	0.36-1.24%
	Expected life	.08 - 4.5 years	3- 7 years
	Expected volatility	165%-167%	168%
	Dividends	0.00%	0.00%

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2014
SCHEDULE OF INVENTORIES
Schedule of Inventory, Current	Inventories consist of the following at March 31, 2014 and December 31, 2013:
		March 31,		31-Dec-13
		2014
	Finished Goods	$	141,636	$	141,636
	Total	$	141,636	$	141,636

NET_LOSS_PER_SHARE_OF_COMMON_S1

NET LOSS PER SHARE OF COMMON STOCK (Tables)	3 Months Ended
	Mar. 31, 2014
SCHEDULE OF NET LOSS PER SHARE OF COMMON STOCK
SCHEDULE OF NET LOSS PER SHARE OF COMMON STOCK	Total shares issuable upon the exercise of warrants and conversion of preferred stock and convertible promissory notes for the three months ended March 31, 2014 and 2013 were as follows:
		March 31,
		2014	2013
	Warrants	175,999,286	148,166,128
	Convertible promissory notes	502,849,869	58,547,970
	Convertible preferred stock	1,545,760	1,545,760
	Total	680,394,915	208,259,858

Schedule_Of_Assets_and_Liabili

Schedule Of Assets and Liabilities Measured at Fair Value (Tables)	3 Months Ended
	Mar. 31, 2014
Schedule Of Assets and Liabilities Measured at Fair Value
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Liabilities measured at fair value on a recurring basis at March 31, 2014 are as follows:
		Quoted Prices in Active Markets for Identical Liabilities		Significant Other Observable Inputs		Significant Unobservable Inputs		Balance
		(Level 1)		(Level 2)		(Level 3)
	Embedded conversion feature	$	–	$	–	$	395,500	$	395,500
	Warrant liability	$	–	$	–	$	123,300	$	123,300
	Balance at March 31, 2014	$	–	$	–	$	518,800	$	518,800
Fair Value, Assets Measured on Recurring Basis, Unobservable Input	The following table provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets measured at fair value on a recurring basis using significant unobservable inputs during the three months ended March 31, 2014.
				Conversion
		Warrants		Feature		Total
	Balance at - December 31, 2013	$	92,500	$	206,500	$	299,000
	Included in stock based compensation		–		–		–
	Change in fair value of derivative liability		32,400		75,400		107,800
	Included in liabilities (debt discount)		–		75,000		75,000
	Included in liabilities (derivative expense)		–		49,600		49,600
	Included in stockholder's equity		-1,600		-11,000		-12,600
	Transfers in and /or out of Level 3		–		–		–
	Balance at - March 31, 2014	$	123,300	$	395,500	$	518,800

SCHEDULE_OF_STOCK_WARRANTS_Tab

SCHEDULE OF STOCK WARRANTS (Tables)	3 Months Ended
	Mar. 31, 2014
SCHEDULE OF STOCK WARRANTS TABLES
Schedule of warrant issuances and warrant balances outstanding	The following tables sets forth information concerning the Company's warrant issuances and warrant balances outstanding as of, and during the three months ended March 31, 2014:
		Shares Underlying Warrants	Weighted Average Exercise Price			Intrinsic Value
	Outstanding at December 31, 2013	176,574,286	$	0.02		$	-
	Granted	-		-			-
	Expired	-500,000		0.135			-
	Exercised	-75,000		0.025			-
	Outstanding at March 31, 2014	175,999,286		0.01			-
Additional information with respect to the Company's warrants Table	The following is additional information with respect to the Company's warrants as of March 31, 2014:
	Number of Warrants	Range of Exercise Price	Weighted Average Remaining Contractual Life (In Years)		Average Exercise Price			Currently Exercisable
	129,078,495	$0.003-$0.0096	3.51		$	0.0051		129,078,495
	44,233,863	$0.0108-$0.0964	1.08		$	0.0362		44,233,863
	2,627,404	$0.1-$0.1884	2.91		$	0.1139		2,627,404
	59,524	$0.84	1.66		$	0.84		59,524
	175,999,286							175,999,286

Assumptions_used_in_the_BlackS

Assumptions used in the Black-Scholes valuation model (Details)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Assumptions used in the Black-Scholes valuation model
Risk-free interest rate	0.03-1.73%	0.36-1.24%
Expected life	3 - 5 years	3- 7 years
Expected volatility	165%-167%	168%
Dividends	0.00%	0.00%

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
GOING CONCERN DETAILS
Net Loss	($510,067)
Working capital deficit	6,000,000
Accumulated deficit	48,800,000
Issued notes payable	100,000
Convertible notes payable	392,000
Issued shares of common stock for the settlement	803,214,844
Accrued interest and fees	$46,689

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Inventories consist of the following
Finished Goods	$141,636	$141,636
Inventories	$141,636	$141,636

NET_LOSS_PER_SHARE_OF_COMMON_S2

NET LOSS PER SHARE OF COMMON STOCK (Details)	Mar. 31, 2014	Mar. 31, 2013
Conversion of preferred stock and convertible promissory
Warrants	176,574,286	148,166,128
Convertible promissory notes	492,877,340	58,547,970
Convertible preferred stock	1,545,760	1,545,760
Total	670,997,386	208,259,858

Liabilities_measured_at_fair_v

Liabilities measured at fair value on a recurring basis (Details) (USD $)	Quoted Prices in Active Markets for Identical Liabilities (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Balance:
Balance of Liabilities measured at fair value at Dec. 31, 2013	$0	$0	$0	$0
Embedded conversion feature	0	0	395,500	395,500
Warrant liability	0	0	123,300	123,300
Balance of Liabilities measured at fair value at Mar. 31, 2014	$0	$0	$518,800	$518,800

Summary_of_the_changes_in_fair

Summary of the changes in fair value using significant unobservable inputs (Details) (USD $)	Warrants	Conversion Feature	Total
Balance of changes in fair value at Dec. 31, 2013	$92,500	$206,500	$299,000
Included in stock based compensation	0	0	0
Change in fair value of derivative liability	32,400	75,400	107,800
Included in liabilities (debt discount)	0	75,000	75,000
Included in liabilities (derivative expense)	0	49,600	49,600
Included in stockholder's equity	-1,600	-11,000	-12,600
Transfers in and /or out of Level 3	0	0	0
Balance of changes in fair value at Mar. 31, 2014	$123,300	$395,500	$518,800

NOTES_PAYABLE_Details

NOTES PAYABLE (Details) (USD $)	Mar. 31, 2014
Notes payable and accrued interest consist of the following
Company issued Promissory Notes in the aggregate principal amount during the period	$90,000
Outstanding principal balance on the notes	$90,000

Common_stock_issued_to_Notes_p

Common stock issued to Notes payable (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
Common stock issued to Notes payable
Shares issued to a note holder on request of conversion of note	25,375,000
Principal amount of note converted in to common stock	$25,000
Fees amount of note converted in to common stock	375
Total shares of common stock issued upon requests from note holders to convert loans with principal plus accrued interest	31,054,520
Total amount of loans with principal plus accrued interest converted	$31,055

Recovered_Sheet1

Convertible promissory notes payable and accrued interest (Details) (USD $)	Mar. 31, 2014	Jan. 31, 2014	25-May-13
Convertible promissory notes payable and accrued interest:
Company issued convertible promissory note in the principal amount		$75,000	$25,000
Conversion price equal to a percentage of the low closing bid price for the twenty days prior to conversion		75.00%	50.00%
Interest rate on convertible notes per annum		10.00%
Total amount reflecting in Company's liabilities	76,229
Accrued interest included in liabilities	$1,229

Commitments_and_contingencies_

Commitments and contingencies Litigation (Details) (USD $)	Jun. 30, 2014	Mar. 10, 2014	Feb. 01, 2014	Dec. 31, 2013	Oct. 04, 2013	Apr. 04, 2013
Commitments and contingencies Litigation
Money damages which have been accrued for and included in accounts payable and accrued liabilities			$475,930
The warrant was originally issued contemporaneously with the issuance of a promissory note to Levin						20,000
The Company entered into a settlement and has agreed to issue a convertible promissory note in the amount to the plaintiff	50,000
Company has accrued a loss as a result of the settlement and is included in accounts payable and accrued liabilities.				50,000
Issuance of principal amount of senior secured redeemable and convertible debentures					275,000
Company converted convertible notes and accrued interest into a new convertible note					531,431
Company converted convertible notes at the request of the lender due to default					303,499
Final judgment was entered against the Company concluding that TCA is entitled to damages in the amount		610,349
Company is reporting a liability of related to the TCA claim and is included in convertible notes payable.				$554,814

Settlement_agreement_with_Tarp

Settlement agreement with Tarpon Bay Partners LLC (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Nov. 27, 2013
Settlement agreement with Tarpon Bay Partners LLC
Tarpon previously purchase outstanding liabilities of the Company from TCA in the amount			$506,431
Tarpon previously purchase outstanding liabilities of the Company from Designs and Project Development Corporation in the amount			56,429
Subject to adjustment and ownership limitations, a convertible promissory note in the principal amount issued			75,000
Company is reporting a liability related to the Designs and Project Development Corporation claim and is included in notes payable.		57,484
Company issued Tarpon a convertible promissory note in the principal amount	75,000
Eviction notice amount subject to a lawsuit and is included in accounts payable and accrued liabilities		54,739
Total amount payable related to the judgment of accounting firm		36,613
Company's right to arbitrate a fee dispute with Steve Legum of legal fees in connection with Mr. Legum's representation of the Company in the Levin Consulting Group matter	12,194
Company has accrued a liability related to the dispute and is included in accounts payable and accrued liabilities	$6,022

Common_stock_Issues_to_Debt_De

Common stock Issues to Debt (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
Common stock Issues to Debt
Total shares of common stock issued upon conversion of loans	31,054,520
The conversion rate per share.	$0.00
Amount of notes and interest converted in to stock	$31,055
Shares of common stock issued to a note lender as penalty shares	13,265,625
Amount recorded as interest expense for this issuance	$47,756
Warrant holder exercised warrants	625,000
Exercise price of warrants	$0.00
Company issued shares of common stock in connection with such exercise	526,315

STOCK_WARRANTS_Details

STOCK WARRANTS (Details)	3 Months Ended
	Mar. 31, 2014
STOCK WARRANTS DETAILS
Warrants were exercised during the period	75,000
Warrants expired during the period	500,000

Warrant_Issuances_and_Warrant_

Warrant Issuances and Warrant Balances Outstanding (Details) (USD $)	Shares Underlying Warrants	Weighted Average Exercise Price	Intrinsic Value
Outstanding at Dec. 31, 2013	176,574,286	0.02	0
Granted	$0	$0	$0
Expired	-500,000	0.135	0
Exercised	($75,000)	$0.03	$0
Outstanding at Mar. 31, 2014	175,999,286	0.01	0

Additional_information_with_re

Additional information with respect to the Company's warrants (Details)	3 Months Ended
	Mar. 31, 2014
Number of Warrants
Range of Exercise Price $0.003-$0.0096	129,078,495
Range of Exercise Price $0.0108-$0.0964	44,233,863
Range of Exercise Price $0.1-$0.1884	2,627,404
Range of Exercise Price $0.84	59,524
Range of Exercise Price	175,999,286
Weighted Average Remaining Contractual Life (In Years)
Range of Exercise Price $0.003-$0.0096	3.51
Range of Exercise Price $0.0108-$0.0964	1.08
Range of Exercise Price $0.1-$0.1884	2.91
Range of Exercise Price $0.84	1.66
Range of Exercise Price	0
Average Exercise Price
Range of Exercise Price $0.003-$0.0096	0.0051
Range of Exercise Price $0.0108-$0.0964	0.0362
Range of Exercise Price $0.1-$0.1884	0.1139
Range of Exercise Price $0.84	0.84
Range of Exercise Price	0
Currently Exercisable
Range of Exercise Price $0.003-$0.0096	129,078,495
Range of Exercise Price $0.0108-$0.0964	44,233,863
Range of Exercise Price $0.1-$0.1884	2,627,404
Range of Exercise Price $0.84	59,524
Range of Exercise Price	175,999,286

Subsequent_events_Issuance_of_

Subsequent events Issuance of Common Stock (Details) (USD $)	Sep. 15, 2014	Jul. 01, 2014	Aug. 27, 2013	Jul. 09, 2013
Subsequent events Issuance of Common Stock
Company received proceeds of for the exercise of warrants			$10,500	$27,923
Company exercised number of warrants			1,093,750	2,389,817
Company issued shares of common stock to the warrant holder			9,545,455	27,202,727
Shares of common stock to a note lender as penalty shares for failing to issue shares timely upon receipt of the conversion notice from the lender	7,027,778	7,634,921
The Company recorded interest expense for issuance of penalty shares	$4,919	$12,979

Subsequent_events_Issuance_of_1

Subsequent events Issuance of Promissory Notes (Details) (USD $)	Apr. 25, 2014
Subsequent events Issuance of Promissory Notes
Promissory Note was issued to a lender in the total amount	$100,000
The note matures on April 30, 2015 with the stated interest rate	8.00%

Subsequent_events_Issuance_of_2

Subsequent events Issuance of Convertible Promissory Notes (Details) (USD $)	Nov. 17, 2014	Nov. 10, 2014	Oct. 22, 2014	Oct. 21, 2014	Sep. 16, 2014	Aug. 13, 2014	Jul. 17, 2014	Jun. 19, 2014	Apr. 21, 2014	Apr. 04, 2014
Subsequent events Issuance of Convertible Promissory Notes
Company issued a convertible promissory note for to a related party	$4,156	$20,000	$14,000	$50,000	$23,000	$85,000	$23,000	$100,000	$2,500	$50,000
The note matures from the issuance date with the stated interest rate	10.00%	10.00%	10.00%	0.00%	10.00%	8.00%	10.00%	10.00%	0.00%	0.00%
The note is convertible into the Company's common stock at a discount of the lowest closing bid price	50.00%	50.00%		50.00%		50.00%	50.00%		50.00%	40.00%
The note is convertible into the Company's common stock at a conversion price per share			$0.00		$0.00		$0.00	$0.00
The warrants fully vested and have a life of 5 years from date of issuance are issued			7,000,000		9,200,000		4,600,000	10,526,316
Warrants were issued with an exercise price per share			$0.00		$0.00		$0.00	$0.00
Company issued another convertible promissory note for to a related party							$20,000